The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants

by | Jun 5, 2026 | Clinical Trials | 0 comments

​ Conditions: Acute Coronary Syndromes (ACS); Recent Myocardial Infarction; Recent Stroke; Peripheral Arterial Disease

Interventions: Drug: CG-0255 Besylate for Injection; Drug: CG-0255 Besylate Capsule; Drug: Clopidogrel

Sponsors: Shanghai CureGene Pharmaceutical Co., Ltd.

Recruiting Conditions: Acute Coronary Syndromes (ACS); Recent Myocardial Infarction; Recent Stroke; Peripheral Arterial Disease
Interventions: Drug: CG-0255 Besylate for Injection; Drug: CG-0255 Besylate Capsule; Drug: Clopidogrel
Sponsors: Shanghai CureGene Pharmaceutical Co., Ltd.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *